Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum

BACKGROUND: The use of poor quality antimalarial medicines, including the use of non-recommended medicines for treatment such as sulfadoxine-pyrimethamine (SP) monotherapy, undermines malaria control and elimination efforts. Furthermore, the use of subtherapeutic doses of the active ingredient(s) ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Dis Model
Autors principals: Brock, Aleisha R., Ross, Joshua V., Greenhalgh, Scott, Durham, David P., Galvani, Alison, Parikh, Sunil, Esterman, Adrian
Format: Artigo
Idioma:Inglês
Publicat: KeAi Publishing 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001968/
https://ncbi.nlm.nih.gov/pubmed/29928735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.idm.2017.04.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars